1 of 1
Story summary
- In 2026, the life sciences sector shows a mixed recovery with improved funding and stock prices.
- Real estate remains weak, showing a 23.2% vacancy rate and declining rents, while more than 55% of labs built from 2020 to 2025 remain vacant.
- Hiring has increased, and venture capital investment reached $7.5 billion in Q1 2026.
- Companies are converting vacant spaces for advanced manufacturing and AI, and experts predict gradual market stabilization driven by AI and automation.
